(VIANEWS) – Shares of Viking Therapeutics (NASDAQ: VKTX) fell 6.56% to $3.56 at 10:35 EST on Monday, after five successive sessions in a row of losses. NASDAQ is sliding 2.72% to $13,768.92, after four consecutive sessions in a row of losses. This seems, up until now, an all-around down trend exchanging session today.
Viking Therapeutics’s last close was $3.81, 62.24% below its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 455442 which is 46.27% below its average volume of 847751.
The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.72%, a negative 1.14%, and a positive 2.82%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 2.72% (last week), 3.19% (last month), and 2.82% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be overbought (>=80).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $3.56 at 10:35 EST, way under its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).